Mealey's (March 6, 2019, 11:08 AM EST) -- FRESNO, Calif. — A California federal judge on Feb. 14 dismissed various claims against Pfizer Inc. and Mylan Institutional Inc. in a wrongful death case involving the anti-arrhythmia heart drug amiodarone (brand name Cordarone) but granted the surviving spouse leave to file an amended complaint (Gilbert Marroquin, et al. v. Pfizer, Inc., et al., No. 18-974, E.D. Calif., 2019 U.S. Dist. LEXIS 25308)....